
Sotera Health Company Common Stock
SHCSotera Health Company (SHC) is a provider of sterilization and lab testing services for the healthcare and pharmaceutical industries. The company specializes in sterilization technologies, including ethylene oxide and gamma irradiation, and offers comprehensive quality control and testing solutions to ensure product safety and compliance. Headquartered in Chicago, Illinois, Sotera Health serves medical device manufacturers, pharmaceutical companies, and other healthcare-related entities worldwide.
Company News
Warburg Pincus, a major shareholder and board member of Sotera Health, sold 9.7 million shares (22.18% of its indirect stake) for $158.7 million on December 3, 2025, at $16.33 per share. Despite the insider selling, Warburg Pincus retains over 34 million shares in the sterilization and lab services company, which has shown strong performance with...
Darsana Capital initiated a new $189 million stake in Wingstop, purchasing 750,000 shares representing 4.45% of their portfolio. Despite recent same-store sales declines, the investment suggests potential long-term growth in the restaurant chain.
Sotera Health Company, a global provider of sterilization solutions and lab services, has appointed Vincent K. Petrella as its new Lead Independent Director, effective January 2, 2025. Petrella, who has served on the company's board since 2020, brings extensive public company leadership experience and will serve as a key liaison between the board...
Sotera Health, a leading global provider of sterilization solutions and lab testing services, will hold an Investor Day in New York City to discuss its strategic positioning and future growth plans, including a long-term financial outlook and a 2025-2027 financial plan.
The pharmaceutical sterility testing market is growing rapidly due to increasing demand for safe and effective pharmaceutical products, advancements in testing technologies, and the rising focus on biopharmaceuticals. The market is expected to reach $3.79 billion by 2032, driven by stringent regulations, the need for sterility testing in new ther...



